C E Mogensen. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Blood Pressure/drug effectsDiabetes Mellitus/physiopathologyDiabetic Nephropathies/prevention & controlFurosemide/therapeutic useGlomerular Filtration Rate/drug effectsHumansHydralazine/therapeutic useHypertension/drug therapyHypertension/etiologyMalePropranolol/therapeutic useUremia/prevention & control
Substances: See more » HydralazineFurosemidePropranolol
Year: 1979 PMID: 85044 DOI: 10.1016/s0140-6736(79)92935-0
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321